Hims & Hers had been selling compounded injectable semaglutide since 2024, positioning it as an affordable alternative to branded GLP-1 drugs during a supply shortage
Impure products can contain harmful contaminants, be underdosed, or have incorrect peptide sequences, which will invalidate research results and pose significant safety risks
98 Pain with filling (hypersensitivity) is consistent with IC/BPS
Skin sensitivity, product strength, age, health status, and personal goals can all change how often someone should use it
Interleukin-6 predicts inflammation-induced increase of glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
Preclinical findings show measurable increases in microvessel density within 7 to 14 days of BPC-157 administration